Marker, lesion localization, implantable
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
10-11-2017
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Available from:
Hologic (Australia & New Zealand) Pty Ltd
Class:
Class IIb
Manufactured by:
Hologic Inc 250 Campus Drive, Marlborough, MA, 01752 United States Of America
Therapeutic area:
40808 - Marker, lesion localization, implantable
Therapeutic indications:
Intended to be implanted to mark tumour/lesions to allow accurate localisation for therapy.
Authorization status:
A
Authorization date:
2013-10-31
